Tag Archives: Canada
Are US and Canadian Rx Policies Converging?
by Tom Norton
As the US pharmaceutical industry anxiously watches the rapid onset of Obamacare, certainly one of the more pressing issues is the debate over the number of drugs that will be reimbursed in each therapeutic class under the Essential Health Benefits (EHB) program. To say that this is a critical concern for the future [...]
Posted in Global, Guest Blog, Legal, Market Access, Strategy, healthcare Also tagged Affordable Care Act, essential health benefits, health insurance, HHS, Medicare, Obamacare Leave a comment
Merck to Close Eight Plants
Image by Getty Images via @daylife
Over the next two years, Merck will shut down eight manufacturing plants, as well as eight research sites, as part of the ongoing Schering-Plough merger process. The company said in a statement that the various site exits will help “create a flexible R&D organization.”
Taking a page out of Pfizer’s book [...]
Posted in Strategy Also tagged business, Factory, Infectious disease, Merck, Research and development, Schering Plough, South America 3 Comments
Pharma Unplugged #2 Layoffs & Bonuses
Pharma Unplugged #2— Layoffs & Bonuses
Recorded: 12/3/2009
Air Date: 12/7/2009
Host: George Koroneos, Pharm Exec
Cohost: Reid Paul, Pharm Rep Magazine
Show Notes:
This week we discuss:
Pfizer’s medical education relationship with the Canadian Medical Association
Journalists take FDA to task for not being transparent enough
Layoffs and job cuts at Sanofi-Aventis
New report shows that DTC receives more funding than sales calls in [...]
Posted in News, Podcasts Also tagged Food and Drug Administration, Medicine, pharma unplugged, podcast, Sanofi-Aventis Leave a comment
H1N1 Vaccine Quantities to Fall Short of Predictions
Image by â– Guerry via Flickr
The US may not have as many H1N1 flu vaccines available from the get-go as originally anticipated, CBS News reported on Tuesday.
According to the report, approximately 45 million doses will be available in mid-October—that’s down from the original plan of 120 million doses. The new plan calls for [...]
Posted in Manufacturing Also tagged GlaxoSmithKline, Health, Influenza, Influenza A virus subtype H1N1, Influenza pandemic, Influenza vaccine 2 Comments

Drug Pipelines in Canada: Is There a Buyer for Future Innovation?